Algo version: 0.98b
Hisamitsu Pharmaceutical is listed at the JPX Exchange
Hisamitsu Pharmaceutical [4530.T]
JPX Sector: Healthcare Industry:Drug Manufacturers—Specialty & Generic

Is Hisamitsu Pharmaceutical stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Hisamitsu Pharmaceutical pays dividends. Last time was Thursday 1st of January 1970 where the investors holding the stock on Thursday 27th of February 2025 were paid JPY0 per share. Over the last 44 times between 2001 and 2025, Hisamitsu Pharmaceutical has paid JPY1220 with an average of JPY27.73 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Hisamitsu Pharmaceutical 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was JPY4 455.00, you would have made a loss of JPY-461.00 per share or -10.35%

Yes, the average daily trading liquidity for Hisamitsu Pharmaceutical is JPY141 966 thousand. You should therefore be able to get in and out of your positions relatively fast.

Hisamitsu Pharmaceutical has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 6.44, the company's ability to pay off the debt is good. Hisamitsu Pharmaceutical has a good net profit margin of 10.11% and should have high tolerances against inflation.

We have calculated the inflation risk for Hisamitsu Pharmaceutical to be low [0.1 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.